Digital PCR and Real-Time PCR Market From Relative to Absolute: The Rise of Digital PCR in the Molecular Diagnostics Market

Digital PCR and Real-Time PCR Market to reach over USD 16.43 billion by the year 2031 - Exclusive Report by InsightAce Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital PCR and Real-Time PCR Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs)- Market Outlook And Industry Analysis 2031"

The global Digital PCR and Real-Time PCR Market is estimated to reach over USD 16.43 billion by 2024-2031, exhibiting a CAGR of 8.02% during the forecast period.

Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1772

Digital PCR: Precise Quantification of Minority Sequences
The end-point digital PCR (dPCR) technique offers a powerful tool for analyzing rare or minority sequences within a background of abundant, similar sequences. Unlike traditional PCR, which relies on agarose gel electrophoresis for semi-quantitative, end-point analysis, dPCR enables absolute quantification of nucleic acids with high precision and sensitivity.

Real-time PCR (qPCR) utilizes fluorescence-based detection to monitor amplicon accumulation throughout the reaction. However, qPCR is limited to relative quantification, requiring normalization to control samples or a standard curve. Additionally, variations in amplification efficiency can affect qPCR results.
Digital PCR comes in three main formats: droplet digital PCR, chip-based digital PCR, and beamed digital PCR. The growing prevalence of diseases like brain tumors, blood cancers, and lung cancer is fueling the expansion of the global digital PCR market. Notably, dPCR assays play a crucial role in diagnosing molecular cancers.

List of Prominent Players in the Digital PCR and Real-Time PCR Market:

• Quidel Corporation
• Quanta Biosciences Inc.
• Sacace Biotechnologies Srl
• Standard Biotools
• Stilla Technologies
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.

• Abbott Laboratories
• Agilent Technologies, Inc.
• Analytik Jena AG
• Becton Dickinson and Company
• Bio Molecular Systems
• Biomeme Inc.
• Biomérieux S.A.
• Bioneer Corporation
• Bio-Rad Laboratories, Inc.
• Cole-Parmer Instrument Company Llc
• Danaher Corporation
• Elitech Group Sas
• Endress+Hauser
• Enzo Life Sciences, Inc.
• Eppendorf AG
• F. Hoffmann-LA Roche Ltd.
• Fluidigm Corporation
• JN Medsys PTE, LTD.
• Merck KGAA
• Meridian Bioscience, Inc.
• Promega Corporation
• Qiagen N.V.

Market Dynamics:
Drivers-
Consumer demand for early disease identification and treatment has pushed research and development of novel genetic approaches and product development. Furthermore, more substantial investment and the availability of funds and incentives are boosting R&D activity. Furthermore, governments and federal organizations around the world are emphasizing the significance of qPCR and dPCR technologies in genomics research.

Again, in the qPCR and dPCR industries over the last decade, various financing attempts by government and private organizations to help genomic research have been noticed.

Challenges:
Globally, significant inflation in industrialized economies has resulted in an overall price increase over the last two years. The cumulatively deteriorating general purchasing power is projected to have a considerable influence on developing economies and is regarded as beneficial in a variety of ways.

The paper examines the impact of high inflation on the global economy's long-term performance and gives information on fiscal policies that measure and mitigate its short-term effects on demand/supply, cash flow, and currency exchange. The Global Digital PCR & Real-Time PCR Market research forecasts substantial inflation, taking into account the influence of cost-push and demand-pull inflation.

Regional Trends:
The North America Digital PCR and Real-Time PCR Market is anticipated to record a significant market share in revenue and is projected to raise at a high CAGR soon. The increased availability of R&D funding for genomic research and the region's robust research infrastructure are driving the expansion of the Digital PCR (dPCR) and Real-Time PCR (qPCR) markets in North America. When compared to other regions, North America is experiencing growth due to the early commercialization of Digital PCR (dPCR) and Real-Time PCR (qPCR) products.

Because of increased financing for Digital PCR (dPCR) and Real-Time PCR (qPCR) technologies, the North American region, including Canada and the United Kingdom, is expected to be the largest market. The Asia Pacific region is expected to witness significant growth opportunities due to rapidly developing economies, increased government support for life science research, an aging population associated with an increase in the incidence of genetic diseases, expanding research, and clinical trial out-sourcing from the region, all of which are expected to increase demand for Digital PCR (dPCR) and Real-Time PCR (qPCR) in the region.

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1772

Recent Developments:
• In October 2022, Roche gained FDA approval to utilize the COVID-19 PCR test on Cobas 6800/8800 systems. One of the first COVID-19 PCR tests conducted on an automated, high-throughput capabilities platform to earn FDA 510(k) clearance is the Cobas SARS-CoV-2 Qualitative test.

Segmentation of Digital PCR and Real-Time PCR Market-
By Product-& Services
• qPCR Product-& Services
o qPCR Reagents and Consumables
o qPCR Instruments
o qPCR Software and Services
• dPCR Product-& Services
o dPCR Reagents and Consumables
o dPCR Instruments
 Chip-based Digital PCR
 Beaming Digital PCR
o dPCR Software and Services)
By Application-
• Clinical Applications
o Infectious Disease Testing
o Oncology Testing
o Blood Screening
o Transplant Diagnostics
o Other Clinical Applications
• Research Applications
• Forensic Applications
• Environmental Applications
• Other Applications
By End-User-
• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Pharmaceutical & Biotechnology
• CROS & CDMOS
• Forensic Laboratories
• Other End-Users
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/report/digital-pcr-and-real-time-pcr-market/1772

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.